Melanoma trial failure deals heavy blow to immunotherapy hopes via @FT
https://t.co/zi4tXV7Ao0— The Propell Group (@ThePropellGroup) April 6, 2018
Melanoma trial failure deals heavy blow to immunotherapy hopes via @FT
https://t.co/zi4tXV7Ao0— The Propell Group (@ThePropellGroup) April 6, 2018